{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:42:25Z","timestamp":1761741745809,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,12]],"date-time":"2012-11-12T00:00:00Z","timestamp":1352678400000},"content-version":"vor","delay-in-days":316,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2012]]},"DOI":"10.6061\/clinics\/2012(11)22","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T12:33:08Z","timestamp":1352291588000},"page":"1349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices"],"prefix":"10.1016","volume":"67","author":[{"given":"Ramon Andrade","family":"De Mello","sequence":"first","affiliation":[]},{"given":"Ant\u00f3nio","family":"Ara\u00fajo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"5","key":"10.6061\/clinics\/2012(11)22_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.6061\/clinics\/2012(05)03","article-title":"Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients","volume":"67","author":"Bacchi","year":"2012","journal-title":"Clinics"},{"issue":"11","key":"10.6061\/clinics\/2012(11)22_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5306\/wjco.v2.i11.367","article-title":"Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies","volume":"2","author":"de Mello","year":"2011","journal-title":"World J Clin Oncol"},{"issue":"10","key":"10.6061\/clinics\/2012(11)22_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.6061\/clinics\/2012(11)22_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ijc.24746","article-title":"Frequency of and variables associated with the EGFR mutation and its subtypes","volume":"126","author":"Tanaka","year":"2010","journal-title":"Int J Cancer"},{"issue":"1","key":"10.6061\/clinics\/2012(11)22_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/JTO.0b013e3181914111","article-title":"Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma","volume":"4","author":"Kosaka","year":"2009","journal-title":"J Thor Oncol"},{"key":"10.6061\/clinics\/2012(11)22_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-012-0465-5","article-title":"EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study","author":"de Mello","year":"2012","journal-title":"Tumour Biol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222022098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222022098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-67-11\/cln-67-11-1349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:10:49Z","timestamp":1761721849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222022098"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1807-59322012001100022&lng=en&nrm=iso","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3488998\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1807593222022098"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2012(11)22","relation":{},"ISSN":["1807-5932"],"issn-type":[{"type":"print","value":"1807-5932"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor receptor mutation frequency and non-small cell lung cancer management: implication for treatment choices","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2012(11)22","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}